Loading...
Cytokine CCL5 and Receptor CCR5 Axis in Glioblastoma Multiforme
BACKGROUND: Glioblastoma is the most frequent and aggressive brain tumour in humans with median survival from 12 to 15 months after the diagnosis. This is mostly due to therapy resistant glioblastoma stem cells in addition to intertumour heterogeneity that is due to infiltration of a plethora of hos...
Na minha lista:
| Udgivet i: | Radiol Oncol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Sciendo
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6884928/ https://ncbi.nlm.nih.gov/pubmed/31747383 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/raon-2019-0057 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|